Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2367402C Stable pharmaceutical dosage form for paroxetine anhydrate
11/23/2010CA2354148C Aerosol formulations for buccal and pulmonary application
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/23/2010CA2332808C Compositions of ascorbic acid derivatives for treatment of skin diseases
11/23/2010CA2319836C Hydroxylation activated prodrugs
11/23/2010CA2315271C Platelet derived growth factor (pdgf) nucleic acid ligand complexes
11/23/2010CA2302700C New use for budesonide and formoterol
11/23/2010CA2302010C 9a-azalides as veterinary antimicrobial agents
11/23/2010CA2252565C Dna vaccine formulations
11/23/2010CA2232738C Strategy for suppressing the expression of an endogenous gene
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/23/2010CA2194501C Method of regulating immune function
11/23/2010CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof
11/21/2010CA2671921A1 Inclusion complex of raloxifene hydrochloride and .beta.-cyclodextrin
11/21/2010CA2666446A1 Compositions for prostate and menstrual/menopausal related health
11/21/2010CA2666444A1 Neuroprotection and prevention of dopamine cell death by targeting nur77 translocation
11/19/2010CA2701484A1 Ondansetron film compositions
11/18/2010WO2010132882A2 Sublingual dexmedetomidine compositions and methods of use thereof
11/18/2010WO2010132879A2 Multicomponent degradable cationic polymers
11/18/2010WO2010132873A2 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
11/18/2010WO2010132864A1 Methods of treating hiv patients with anti-fibrotics
11/18/2010WO2010132852A2 Protease inhibitors
11/18/2010WO2010132839A2 Aminoglycoside dosing regimens
11/18/2010WO2010132838A1 Compounds useful for treating disorders related to trpa1
11/18/2010WO2010132821A2 Methods and compositions for treating degenerative and ischemic disorders
11/18/2010WO2010132810A1 Deuterium modified benzimidazoles
11/18/2010WO2010132787A1 Methods of treating proliferative diseases
11/18/2010WO2010132777A2 Treatment of urinary tract infections with antibacterial aminoglycoside compounds
11/18/2010WO2010132770A1 Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
11/18/2010WO2010132768A1 Antibacterial derivatives of sisomicin
11/18/2010WO2010132760A1 Antibacterial derivatives of tobramycin
11/18/2010WO2010132759A1 Antibacterial derivatives of dibekacin
11/18/2010WO2010132743A1 Corticosteroid beta-agonist compounds for use in therapy
11/18/2010WO2010132696A1 Ranolazine for the treatment of cns disorders
11/18/2010WO2010132693A2 Oligomer-containing pyrrolidine compounds
11/18/2010WO2010132691A1 Oligomer-containing substituted aromatic triazine compounds
11/18/2010WO2010132684A2 Inhibitors of inv(16) leukemia
11/18/2010WO2010132664A1 Compositions and methods for drug delivery
11/18/2010WO2010132663A1 Pegylated azapeptide derivatives as hiv protease inhibitors
11/18/2010WO2010132662A1 Powder formulations of potassium-binding active agents
11/18/2010WO2010132657A1 Compositions and methods for treating ischemia and ischemia-reperfusion injury
11/18/2010WO2010132635A1 Burst drug release compositions
11/18/2010WO2010132615A1 Hydrazone compounds and their use
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132599A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010WO2010132598A1 Heteroaryl compounds as pikk inhibitors
11/18/2010WO2010132596A1 Use of picoplatin to treat colorectal cancer
11/18/2010WO2010132594A1 Use of picoplatin to treat prostate cancer
11/18/2010WO2010132580A2 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
11/18/2010WO2010132562A2 Transdermal delivery of metformin
11/18/2010WO2010132554A2 Diaza heterocyclic compounds for phototherapy
11/18/2010WO2010132547A2 Oxaza heterocyclic compounds for phototherapy
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010132525A1 Compounds containing acyclic n-o bonds for phototherapy
11/18/2010WO2010132521A1 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof
11/18/2010WO2010132520A1 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
11/18/2010WO2010132515A1 Compounds containing acyclic n-n bonds for phototherapy
11/18/2010WO2010132511A1 Methods of reducing the risk of dronedarone use in certain patient populations
11/18/2010WO2010132507A2 Methods for treatment of disease using an epimetabolic shifter (coenzyme q10)
11/18/2010WO2010132502A2 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
11/18/2010WO2010132498A1 Vascular disrupting agents for treatment of polypoidal choroidal vasculopathy
11/18/2010WO2010132494A1 Compounds and methods for treating aids and hiv infections
11/18/2010WO2010132487A1 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
11/18/2010WO2010132445A1 Solid forms and process for preparing
11/18/2010WO2010132440A2 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
11/18/2010WO2010132434A1 Determining the severity of 5-fluorouracil overdose
11/18/2010WO2010132423A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
11/18/2010WO2010132402A1 Lipid-polymer conjugates, their preparation and uses thereof
11/18/2010WO2010132390A2 Method of decreasing ubiquitylated protein levels
11/18/2010WO2010132352A2 Spiro compounds and their use as therapeutic agents
11/18/2010WO2010132347A2 Docosahexaenoic acid for the treatment of heart failure
11/18/2010WO2010132334A1 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
11/18/2010WO2010132286A1 Orally administered tablet formulation of an antianxiolytic compound
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010132233A1 Combination antineoplastic therapy
11/18/2010WO2010132128A1 Method of improving cognitve functions in individuals with down syndrome and/or alzheimer's disease
11/18/2010WO2010132110A1 Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
11/18/2010WO2010132072A1 Treatment or prevention of migraine by dosing at aura
11/18/2010WO2010132047A1 Guanosine/gmp gels and uses thereof
11/18/2010WO2010132024A1 Lycopene and resveratrol compositions for nk cell activation resulting in anti-neoplastic effect
11/18/2010WO2010132021A1 Lycopene and resveratrol dietary supplement
11/18/2010WO2010132016A1 Bis-(sulfonylamino) derivatives for treatment of pain and inflammation
11/18/2010WO2010132015A1 New compounds modulating gamma-secretase and their use in the treatment of alpha beta related pathologies, such as alzheimer's disease
11/18/2010WO2010131962A2 Lysine compounds and their use in site- and chemoselective modification of peptides and proteins
11/18/2010WO2010131922A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same
11/18/2010WO2010131887A2 Composition for preventing hair loss or for stimulating hair growth
11/18/2010WO2010131865A2 Antimicrobial composition with an activity against an antibiotic-resistant strain
11/18/2010WO2010131777A1 Fine particles of crystalline polyol and method of preparing same
11/18/2010WO2010131769A1 Treatment of diffuse-type gastric cancers using s-1 and cisplatin
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131718A1 Anti-hyperglycemic and/or anti-hyperlipidemic agent comprising material containing avian skin-derived sphingomyelin as active ingredient
11/18/2010WO2010131717A1 Prion protein structure transformation inhibitor and utilization of same
11/18/2010WO2010131712A1 Therapeutic pharmaceutical agent for diseases associated with decrease in function of gne protein, food composition, and food additive
11/18/2010WO2010131704A1 Test agent for visceral obesity and use thereof
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131691A1 Polyketide compound
11/18/2010WO2010131675A1 Polymer conjugate of bioactive substance having hydroxy group
11/18/2010WO2010131669A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/18/2010WO2010131663A1 Oxamide derivative
1 ... 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 ... 7860